Clinical Trial Update: Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of dose-dense therapy with bevacizumab in colorectal cancer and other solid tumors was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Colorectal Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: TERMINATED